OraSure appoints John D. Bertrand to board, enters cooperation with Altai Capital, seeks declassification

ORASURE TECHNOLOGIES INC

John D. Bertrand appointed as independent Class II director effective April 16, 2026; term expires at 2026 annual meeting.
Altai Capital withdraws its director nominations and stockholder proposal under the Cooperation Agreement.
Board to propose amendment to declassify the board at 2026 annual meeting, phasing in annual elections.
Altai agrees to standstill and voting provisions; Bertrand joins Nominating and Corporate Governance Committee.
Bertrand co-founded Digital Diagnostics; brings AI/diagnostics experience to OraSure's transformation strategy.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

ORASURE TECHNOLOGIES INC entered into Cooperation Agreement with Altai Capital Management, L.P. and Altai Capital Management, LLC (collectively, Altai) (effective 2026-04-16).

Action: entry
Counterparty: Altai Capital Management, L.P. and Altai Capital Management, LLC (collectively, Altai)
Effective: 2026-04-16

Exact text from the filing

On April 16, 2026, OraSure Technologies, Inc. (the “Company”) announced its entry into a cooperation agreement (the “Cooperation Agreement”) with Altai Capital Management, L.P. and Altai Capital Management, LLC (collectively, “Altai”).

View on SEC.gov

Browse all material agreements →

ORASURE TECHNOLOGIES INC filing history →

Source: SEC EDGAR

accession 0001193125-26-160336

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.